Swine flu pandemic

X-Vax Technology Appoints Varsha K. Jain, MD as Chief Clinical Development Officer

Retrieved on: 
Wednesday, July 21, 2021

PALM BEACH GARDENS, Fla., July 21, 2021 /PRNewswire/ -- X-Vax Technology, Inc. (X-VAX), a biotechnology company developing vaccines based on a new approach that mediates the killing of infected cells, today announced the appointment of Varsha K. Jain, MD as Chief Clinical Development Officer.

Key Points: 
  • PALM BEACH GARDENS, Fla., July 21, 2021 /PRNewswire/ -- X-Vax Technology, Inc. (X-VAX), a biotechnology company developing vaccines based on a new approach that mediates the killing of infected cells, today announced the appointment of Varsha K. Jain, MD as Chief Clinical Development Officer.
  • Previously, Dr. Jain served as Senior Program Officer, Vaccine Development and Surveillance at the Bill and Melinda Gates Foundation.
  • Earlier in her career, she oversaw influenza, herpes and Lyme disease vaccine programs in Global Vaccine Discovery and Development at GlaxoSmithKline (GSK).
  • Reporting to Varsha K. Jain, MD will be Guissou Dabiri, PhD, who joined X-VAX as Head of Scientific Communications, and Michael Schwartz, Head of Clinical Trials Management.

Global H1N1 Vaccines Markets Report 2021: Market Reached a Value of $1.8 Billion in 2020 - Forecast to 2026

Retrieved on: 
Friday, April 23, 2021

b'DUBLIN, April 23, 2021 /PRNewswire/ -- The "H1N1 Vaccines Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026" report has been added to ResearchAndMarkets.com\'s offering.\nThe global H1N1 vaccines market reached a value of US$ 1.8 Billion in 2020.

Key Points: 
  • b'DUBLIN, April 23, 2021 /PRNewswire/ -- The "H1N1 Vaccines Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026" report has been added to ResearchAndMarkets.com\'s offering.\nThe global H1N1 vaccines market reached a value of US$ 1.8 Billion in 2020.
  • Looking forward, the global H1N1 vaccines market to exhibit moderate growth during the next five years.\nThe H1N1 virus is an infectious disease characterized by a persistent cough, high fever, red-watery eyes, body aches and headache.
  • The illness is known to have a detrimental effect on the existing chronic ailments, such as Pneumonia, Chronic Obstructive Pulmonary Disease (COPD) and Bronchitis, and can be fatal in severe cases.
  • H1N1 vaccines are a preventive measure administered through intradermal and intranasal procedures to provide active immunization against the virus.\nIncreasing incidences of epidemic H1N1 infection and declining immunity of the general population are among the key factors driving the market growth.

Global H1N1 Vaccines Markets, Opportunity and Forecast Report 2021-2026: Analysis of Key Brands - Agripal, Fiuarix, Influgen, Influvac, Nasovac, & Vaxigrip - ResearchAndMarkets.com

Retrieved on: 
Monday, April 19, 2021

b'The "H1N1 Vaccines Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026" report has been added to ResearchAndMarkets.com\'s offering.\nThe global H1N1 vaccines market reached a value of US$ 1.8 Billion in 2020.

Key Points: 
  • b'The "H1N1 Vaccines Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026" report has been added to ResearchAndMarkets.com\'s offering.\nThe global H1N1 vaccines market reached a value of US$ 1.8 Billion in 2020.
  • Looking forward, the global H1N1 vaccines market to exhibit moderate growth during the next five years.\nThe H1N1 virus is an infectious disease characterized by a persistent cough, high fever, red-watery eyes, body aches and headache.
  • The illness is known to have a detrimental effect on the existing chronic ailments, such as Pneumonia, Chronic Obstructive Pulmonary Disease (COPD) and Bronchitis, and can be fatal in severe cases.
  • H1N1 vaccines are a preventive measure administered through intradermal and intranasal procedures to provide active immunization against the virus.\nIncreasing incidences of epidemic H1N1 infection and declining immunity of the general population are among the key factors driving the market growth.

NTHU Research Team Develops Groundbreaking Influenza Vaccine

Retrieved on: 
Friday, March 12, 2021

With this situation in mind, a research team led by Professor Wu Suh-Chin of the Department of Medical Science has developed a vaccine providing protection against all strains of influenza.

Key Points: 
  • With this situation in mind, a research team led by Professor Wu Suh-Chin of the Department of Medical Science has developed a vaccine providing protection against all strains of influenza.
  • View the full release here: https://www.businesswire.com/news/home/20210312005008/en/
    A research team led by Professor Wu Suh-Chin of the Department of Medical Science has developed a mucosal vaccine providing protection against all strains of influenza, and is currently planning to develop a mucosal COVID-19 vaccine.
  • Since influenza viruses are mainly transmitted through the respiratory tract, Wu's team invented a nasal spray influenza vaccine that is more effective than an injection.
  • Spurred on by the encouraging results, the team is currently planning to develop a mucosal vaccine providing protection against COVID-19.

Children’s Hospital Los Angeles Offers FREE Flu Vaccination Family Clinic

Retrieved on: 
Thursday, December 10, 2020

Get your free flu shot at select CHLA Specialty Care Centers.

Key Points: 
  • Get your free flu shot at select CHLA Specialty Care Centers.
  • Available for the whole family.
  • www.CHLA.org/events
    The American Academy of Pediatrics, the Centers for Disease Control and Prevention, and the Infectious Diseases Society of America recommends everyone over 6 months of age receive the flu vaccine every year.
  • With COVID-19 numbers at critical levels, its now more crucial than ever to be vigilant about your familys health.

Health Officials Stress Importance of Flu Vaccinations Amid the Rise in COVID-19 Cases During National Influenza Vaccination Week (December 6-13)

Retrieved on: 
Wednesday, December 9, 2020

With the recent spike in COVID-19 cases, a severe flu season could mean dangerous, simultaneous respiratory infections that could overrun already stressed clinics and hospitals.

Key Points: 
  • With the recent spike in COVID-19 cases, a severe flu season could mean dangerous, simultaneous respiratory infections that could overrun already stressed clinics and hospitals.
  • "And this year, getting the flu shot is ever more critical as health officials work to avoid a dangerous and even deadly 'twindemic' of people getting the flu in addition to COVID-19."
  • Getting a flu vaccine has been shown to reduce the risk of getting sick, being hospitalized or dying from flu.
  • In 2019-2020, flu vaccination prevented an estimated 7.52 million illnesses, 3.69 million medical visits, 105,000 hospitalizations and 6,300 deaths due to influenza.

Walgreens Flu Index® Reveals Flu Activity for the 2020-2021 Flu Season

Retrieved on: 
Wednesday, December 9, 2020

Users can search by market or state to see where their geographic area ranks for flu activity in any given week, as well as how current flu activity compares to last season.

Key Points: 
  • Users can search by market or state to see where their geographic area ranks for flu activity in any given week, as well as how current flu activity compares to last season.
  • On a weekly basis, we track the incremental change of antiviral medications used to treat influenza across thousands of Walgreens and Duane Reade locations nationwide to create the Walgreens Flu Index.
  • The Walgreens Flu Index is updated weekly each Tuesday and is available through an online, interactive map, linked here .
  • For example, red regions on the Walgreens Flu Index map indicates a much higher than a normal flu season, while green regions indicate a much lower than normal flu season.

Children’s Hospital Los Angeles Offers FREE Flu Vaccination Family Clinic

Retrieved on: 
Friday, December 4, 2020

The American Academy of Pediatrics, the Centers for Disease Control and Prevention, and the Infectious Diseases Society of America recommends everyone over 6 months of age receive the flu vaccine every year.

Key Points: 
  • The American Academy of Pediatrics, the Centers for Disease Control and Prevention, and the Infectious Diseases Society of America recommends everyone over 6 months of age receive the flu vaccine every year.
  • With COVID-19 numbers still at dangerous levels, its now more crucial than every to be vigilant about your familys health.

Blue Cross Blue Shield of Massachusetts Offers Free Bluebikes Rides During National Influenza Vaccination Week

Retrieved on: 
Thursday, December 3, 2020

BOSTON, Dec. 3, 2020 /PRNewswire/ --In support of public health efforts to encourage flu vaccinations and to provide an easy mode of transportation to flu shot locations across Metro-Boston, Blue Cross Blue Shield of Massachusetts ("Blue Cross") will offer free Bluebikes rides during National Influenza Vaccination Week , December 6-12.

Key Points: 
  • BOSTON, Dec. 3, 2020 /PRNewswire/ --In support of public health efforts to encourage flu vaccinations and to provide an easy mode of transportation to flu shot locations across Metro-Boston, Blue Cross Blue Shield of Massachusetts ("Blue Cross") will offer free Bluebikes rides during National Influenza Vaccination Week , December 6-12.
  • Blue Cross is the title sponsor of Bluebikes, which is owned by the municipalities.
  • To take advantage of Blue Cross' free ride offer, riders can download and open the Bluebikes app on a mobile device and use the code "BLUECROSSMA" to unlock a free Adventure Pass.
  • National Influenza Vaccination Week is a national awareness week recognized by the Centers for Disease Control and Prevention (CDC) to highlight the importance of influenza vaccination.

Children’s Hospital Los Angeles Offers FREE Flu Vaccination Family Clinic

Retrieved on: 
Tuesday, December 1, 2020

The American Academy of Pediatrics, the Centers for Disease Control and Prevention, and the Infectious Diseases Society of America recommends everyone over 6 months of age receive the flu vaccine every year.

Key Points: 
  • The American Academy of Pediatrics, the Centers for Disease Control and Prevention, and the Infectious Diseases Society of America recommends everyone over 6 months of age receive the flu vaccine every year.
  • With COVID-19 numbers still at dangerous levels, its now more crucial than every to be vigilant about your familys health.